Notably, the model retained efficacy in early-stage detection (AUC = 0.7598).<h4>Conclusion</h4>This study identifies a novel serum protein panel (INPP1/ARHGAP25) as a minimally invasive tool for breast cancer diagnosis, particularly valuable for early-stage screening. Here, ARHGAP25 is linked to breast carcinoma.